ATR-FTIR Characterization of Janus Nanoparticles-Part II: Follow-Up Skin Application

J Pharm Sci. 2019 Oct;108(10):3366-3371. doi: 10.1016/j.xphs.2019.06.018. Epub 2019 Jun 28.

Abstract

Attenuated total reflection by Fourier transform infrared (ATR-FTIR) was used to implement reliable infrared descriptors over time of Janus nanoparticles (JNP), to follow their behavior before and after cutaneous application. In the last study, ATR-FTIR spectroscopic analysis allowed us to identify the evolution of intensity ratio of ν(C=O) at 1739 cm-1 and δ(H-O-H) at 1639 cm-1 as a spectroscopic descriptor, for JNP before cutaneous application (on the CaF2 window). This descriptor can be used to follow the physical stability (presence) of nanoparticles over time. The purpose of this study was to understand the behavior of JNP on the surface of the human skin. Therefore, a comparative study with the untreated skin and the skin after cutaneous application of lipophilic phase (Labrafil) of JNP was conducted using Franz cells. The suitability of the ATR-FTIR descriptor of JNP was evaluated, and a research of other descriptors was performed to understand the interaction that may exist between nanoparticles and the skin.

Keywords: ATR-FTIR; Janus nanoparticles; Labrafil; cutaneous application; skin; spectroscopic descriptors.

MeSH terms

  • Ataxia Telangiectasia Mutated Proteins / chemistry*
  • Female
  • Follow-Up Studies
  • Humans
  • Nanoparticles / chemistry*
  • Skin / drug effects*
  • Spectroscopy, Fourier Transform Infrared / methods

Substances

  • ATR protein, human
  • Ataxia Telangiectasia Mutated Proteins